Neoflow Technologies
About
Technology stack
detected 2026-06-08No comments yet. Be the first to share your take.
What does Neoflow Technologies do?
Neoflow Technologies Ltd. is a medical device startup focused on developing a novel endovascular solution for the treatment of vasospasm, a critical complication of aneurysmal subarachnoid hemorrhage (aSAH). Vasospasm can lead to delayed ischemic neurological deficit (DIND), a major cause of morbidity and mortality in aSAH patients.
How much funding has Neoflow Technologies raised?
Neoflow Technologies has raised a total of $10M in funding. The most recent round on record is Seed.
Where is Neoflow Technologies headquartered?
Neoflow Technologies is headquartered in Tel Aviv, Israel.
When was Neoflow Technologies founded?
Neoflow Technologies was founded in 2022.
What industry does Neoflow Technologies operate in?
Neoflow Technologies operates in Healthcare, Medical Device, MedTech, HealthTech, Biotechnology, Drug Discovery.
What is Neoflow Technologies's current status?
Neoflow Technologies's current operating status is: Inactive.
What is Neoflow Technologies's revenue?
StartupHub estimates Neoflow Technologies's annual revenue at $2.9M (range $1.5M to $4.8M, 30% confidence), based on comparable companies in the sector.
What is Neoflow Technologies's valuation?
StartupHub estimates Neoflow Technologies's effective valuation at $38.6M (range $25.0M to $60.0M, 10% confidence), based on comparable companies in the sector.